{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:06:07Z","timestamp":1787061967513,"version":"build-2736575974"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-19-127-01-CSM"],"award-info":[{"award-number":["RSG-19-127-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10555-021-09965-3","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T02:43:43Z","timestamp":1618454623000},"page":"413-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Emerging roles for myeloid immune cells in bone metastasis"],"prefix":"10.1007","volume":"40","author":[{"given":"Massar","family":"Alsamraae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-7419","authenticated-orcid":false,"given":"Leah M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"9965_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S., & Weinberg, R. A. (2011). Tumor metastasis: molecular insights and evolving paradigms. Cell, 147, 275\u2013292.","journal-title":"Cell"},{"key":"9965_CR2","first-page":"44","volume":"64","author":"P Marie","year":"1997","unstructured":"Marie, P. (1997). Growth factors and bone formation in osteoporosis: roles for IGF-I and TGF-beta. Revue du Rhumatisme (English Ed.), 64, 44\u201353.","journal-title":"Revue du Rhumatisme (English Ed.)"},{"key":"9965_CR3","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1016\/S8756-3282(96)00138-X","volume":"19","author":"TA Linkhart","year":"1996","unstructured":"Linkhart, T. A., Mohan, S., & Baylink, D. J. (1996). Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone, 19, 1S\u201312S.","journal-title":"Bone"},{"key":"9965_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10238-006-0117-4","volume":"6","author":"D Ribatti","year":"2006","unstructured":"Ribatti, D., Mangialardi, G., & Vacca, A. (2006). Stephen Paget and the \u2018seed and soil\u2019 theory of metastatic dissemination. Clinical and Experimental Medicine, 6, 145\u2013149.","journal-title":"Clinical and Experimental Medicine"},{"key":"9965_CR5","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/ijc.26031","volume":"128","author":"RR Langley","year":"2011","unstructured":"Langley, R. R., & Fidler, I. J. (2011). The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs. International Journal of Cancer, 128, 2527\u20132535.","journal-title":"International Journal of Cancer"},{"key":"9965_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0030-5898(20)31258-X","volume":"15","author":"AL Boskey","year":"1984","unstructured":"Boskey, A. L., & Posner, A. S. (1984). Bone structure, composition, and mineralization. The Orthopedic Clinics of North America, 15, 597\u2013612.","journal-title":"The Orthopedic Clinics of North America"},{"key":"9965_CR7","doi-asserted-by":"crossref","unstructured":"Kitaura, H., et al. (2020). Osteocyte-related cytokines regulate osteoclast formation and bone resorption. International Journal of Molecular Sciences, 21.","DOI":"10.3390\/ijms21145169"},{"key":"9965_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa, N., Koide, M., Nakamura, M., Nakamichi, Y., Yamashita, T., Uehara, S., Kobayashi, Y., Furuya, Y., Yasuda, H., Fukuda, C., & Tsuda, E. (2021). Osteoclast differentiation by RANKL and OPG signaling pathways. Journal of Bone and Mineral Metabolism, 39, 19\u201326.","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"9965_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11914-017-0403-y","volume":"15","author":"MM McDonald","year":"2017","unstructured":"McDonald, M. M., & Delgado-Calle, J. (2017). Sclerostin: an emerging target for the treatment of cancer-induced bone disease. Current Osteoporosis Reports, 15, 532\u2013541.","journal-title":"Current Osteoporosis Reports"},{"key":"9965_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/0026-0495(76)90124-4","volume":"25","author":"AM Parfitt","year":"1976","unstructured":"Parfitt, A. M. (1976). The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism, 25, 909\u2013955.","journal-title":"Metabolism"},{"key":"9965_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11914-020-00645-9","volume":"19","author":"R Hua","year":"2021","unstructured":"Hua, R., Zhang, J., Riquelme, M. A., & Jiang, J. X. (2021). Connexin gap junctions and hemichannels link oxidative stress to skeletal physiology and pathology. Current Osteoporosis Reports, 19, 66\u201374.","journal-title":"Current Osteoporosis Reports"},{"key":"9965_CR12","doi-asserted-by":"publisher","first-page":"145362","DOI":"10.1016\/j.gene.2020.145362","volume":"771","author":"IY Karkache","year":"2021","unstructured":"Karkache, I. Y., Damodaran, J. R., Molstad, D. H. H., & Bradley, E. W. (2021). Serine\/threonine phosphatases in osteoclastogenesis and bone resorption. Gene, 771, 145362.","journal-title":"Gene"},{"key":"9965_CR13","unstructured":"Rowe, P., Koller, A., & Sharma, S. (2021). Physiology, bone remodeling. In StatPearls. Treasure Island (FL)."},{"key":"9965_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10555-014-9494-4","volume":"33","author":"LM Cook","year":"2014","unstructured":"Cook, L. M., Shay, G., Araujo, A., & Lynch, C. C. (2014). Integrating new discoveries into the \u201cvicious cycle\u201d paradigm of prostate to bone metastases. Cancer Metastasis Reviews, 33, 511\u2013525.","journal-title":"Cancer Metastasis Reviews"},{"key":"9965_CR15","doi-asserted-by":"publisher","first-page":"29384","DOI":"10.1038\/srep29384","volume":"6","author":"LM Cook","year":"2016","unstructured":"Cook, L. M., Araujo, A., Pow-Sang, J. M., Budzevich, M. M., Basanta, D., & Lynch, C. C. (2016). Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer. Scientific Reports, 6, 29384.","journal-title":"Scientific Reports"},{"key":"9965_CR16","doi-asserted-by":"crossref","unstructured":"Esposito, M., Guise, T., & Kang, Y. (2018). The biology of bone metastasis. Cold Spring Harbor Perspectives in Medicine, 8.","DOI":"10.1101\/cshperspect.a031252"},{"key":"9965_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","volume":"6","author":"RE Coleman","year":"2020","unstructured":"Coleman, R. E., Croucher, P. I., Padhani, A. R., Cl\u00e9zardin, P., Chow, E., Fallon, M., Guise, T., Colangeli, S., Capanna, R., & Costa, L. (2020). Bone metastases. Nature Reviews. Disease Primers, 6, 83.","journal-title":"Nature Reviews. Disease Primers"},{"key":"9965_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11914-018-0480-6","volume":"16","author":"SC Lin","year":"2018","unstructured":"Lin, S. C., Yu-Lee, L. Y., & Lin, S. H. (2018). Osteoblastic factors in prostate cancer bone metastasis. Current Osteoporosis Reports, 16, 642\u2013647.","journal-title":"Current Osteoporosis Reports"},{"key":"9965_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1254\/fpj.153.11","volume":"153","author":"H Yasuda","year":"2019","unstructured":"Yasuda, H. (2019). The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis - possible applications of anti-RANKL antibody to the treatment of cancer patients. Nihon Yakurigaku Zasshi, 153, 11\u201315.","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"9965_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/107327481502200114","volume":"22","author":"JS Frieling","year":"2015","unstructured":"Frieling, J. S., Basanta, D., & Lynch, C. C. (2015). Current and emerging therapies for bone metastatic castration-resistant prostate cancer. Cancer Control, 22, 109\u2013120.","journal-title":"Cancer Control"},{"key":"9965_CR21","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/bcp.13852","volume":"85","author":"MR Dionisio","year":"2019","unstructured":"Dionisio, M. R., et al. (2019). Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss. British Journal of Clinical Pharmacology, 85, 1114\u20131124.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"9965_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/mc.23192","volume":"59","author":"CL Ihle","year":"2020","unstructured":"Ihle, C. L., & Owens, P. (2020). Integrating the immune microenvironment of prostate cancer induced bone disease. Molecular Carcinogenesis, 59, 822\u2013829.","journal-title":"Molecular Carcinogenesis"},{"key":"9965_CR23","doi-asserted-by":"crossref","unstructured":"Wu, C., Hua, Q., & Zheng, L. (2020). Generation of myeloid cells in cancer: the spleen matters. Frontiers in Immunology, 11.","DOI":"10.3389\/fimmu.2020.01126"},{"key":"9965_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cmi.2011.47","volume":"9","author":"E Zhao","year":"2012","unstructured":"Zhao, E., Xu, H., Wang, L., Kryczek, I., Wu, K., Hu, Y., Wang, G., & Zou, W. (2012). Bone marrow and the control of immunity. Cellular & Molecular Immunology, 9, 11\u201319.","journal-title":"Cellular & Molecular Immunology"},{"key":"9965_CR25","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3389\/fimmu.2018.01977","volume":"9","author":"RM Awad","year":"2018","unstructured":"Awad, R. M., De Vlaeminck, Y., Maebe, J., Goyvaerts, C., & Breckpot, K. (2018). Turn back the TIMe: targeting tumor infiltrating myeloid cells to revert cancer progression. Frontiers in Immunology, 9, 1977.","journal-title":"Frontiers in Immunology"},{"key":"9965_CR26","doi-asserted-by":"publisher","first-page":"226ra232-226ra2","DOI":"10.1126\/scitranslmed.3008095","volume":"6","author":"D Zamarin","year":"2014","unstructured":"Zamarin, D., et al. (2014). Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy. Science Translational Medicine, 6, 226ra232-226ra232.","journal-title":"Science Translational Medicine"},{"key":"9965_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","volume":"26","author":"NV Serbina","year":"2008","unstructured":"Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008). Monocyte-mediated defense against microbial pathogens. Annual Review of Immunology, 26, 421\u2013452.","journal-title":"Annual Review of Immunology"},{"key":"9965_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00780","volume":"4","author":"E Kylmaoja","year":"2018","unstructured":"Kylmaoja, E., et al. (2018). Peripheral blood monocytes show increased osteoclast differentiation potential compared to bone marrow monocytes. Heliyon, 4, e00780.","journal-title":"Heliyon"},{"key":"9965_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1568010054022024","volume":"4","author":"N Fujiwara","year":"2005","unstructured":"Fujiwara, N., & Kobayashi, K. (2005). Macrophages in inflammation. Current Drug Targets. Inflammation and Allergy, 4, 281\u2013286.","journal-title":"Current Drug Targets. Inflammation and Allergy"},{"key":"9965_CR30","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.4049\/jimmunol.141.5.1516","volume":"141","author":"PH Hart","year":"1988","unstructured":"Hart, P. H., & Whitty, G. A. (1988). Piccoli, D.S. & Hamilton, J.A. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. Journal of Immunology, 141, 1516\u20131521.","journal-title":"Journal of Immunology"},{"key":"9965_CR31","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.4049\/jimmunol.158.6.2911","volume":"158","author":"F Randow","year":"1997","unstructured":"Randow, F., et al. (1997). In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. Journal of Immunology, 158, 2911\u20132918.","journal-title":"Journal of Immunology"},{"key":"9965_CR32","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.4049\/jimmunol.158.6.2862","volume":"158","author":"DS Bundschuh","year":"1997","unstructured":"Bundschuh, D. S., et al. (1997). Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. Journal of Immunology, 158, 2862\u20132871.","journal-title":"Journal of Immunology"},{"key":"9965_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L., & Pollard, J. W. (2018). Targeting macrophages: therapeutic approaches in cancer. Nature Reviews Drug Discovery, 17, 887\u2013904.","journal-title":"Nature Reviews Drug Discovery"},{"key":"9965_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon, S. (2003). Alternative activation of macrophages. Nature Reviews. Immunology, 3, 23\u201335.","journal-title":"Nature Reviews. Immunology"},{"key":"9965_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2174\/1871520616666160520112622","volume":"16","author":"J Zhu","year":"2016","unstructured":"Zhu, J., Zhi, Q., P. Zhou, B., Tao, M., Liu, J., & Li, W. (2016). The role of tumor associated macrophages in the tumor nicroenvironment: mechanism and functions. Anti-Cancer Agents in Medicinal Chemistry, 16, 1133\u20131141.","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"9965_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1479-5876-9-177","volume":"9","author":"TL Rogers","year":"2011","unstructured":"Rogers, T. L., & Holen, I. (2011). Tumour macrophages as potential targets of bisphosphonates. Journal of Translational Medicine, 9, 177.","journal-title":"Journal of Translational Medicine"},{"key":"9965_CR37","doi-asserted-by":"crossref","unstructured":"Bianchini, R., Karagiannis, S. N., Jordakieva, G., & Jensen-Jarolim, E. (2020). The Role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer. International Journal of Molecular Sciences, 21.","DOI":"10.3390\/ijms21145017"},{"key":"9965_CR38","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1158\/0008-5472.CAN-06-1210","volume":"67","author":"Y Lu","year":"2007","unstructured":"Lu, Y., Cai, Z., Xiao, G., Keller, E. T., Mizokami, A., Yao, Z., Roodman, G. D., & Zhang, J. (2007). Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Research, 67, 3646\u20133653.","journal-title":"Cancer Research"},{"key":"9965_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1593\/neo.06280","volume":"8","author":"RD Loberg","year":"2006","unstructured":"Loberg, R. D., Day, L. S. L., Harwood, J., Ying, C., St. John, L. N., Giles, R., Neeley, C. K., & Pienta, K. J. (2006). CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia, 8, 578\u2013586.","journal-title":"Neoplasia"},{"key":"9965_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10555-006-9027-x","volume":"25","author":"MJ Craig","year":"2006","unstructured":"Craig, M. J., & Loberg, R. D. (2006). CCL2 (monocyte chemoattractant protein-1) in cancer bone metastases. Cancer Metastasis Reviews, 25, 611\u2013619.","journal-title":"Cancer Metastasis Reviews"},{"key":"9965_CR41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1593\/neo.09988","volume":"11","author":"K Mizutani","year":"2009","unstructured":"Mizutani, K., Sud, S., McGregor, N. A., Martinovski, G., Rice, B. T., Craig, M. J., Varsos, Z. S., Roca, H., & Pienta, K. J. (2009). The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia, 11, 1235\u20131242.","journal-title":"Neoplasia"},{"key":"9965_CR42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/j.1349-7006.2008.00880.x","volume":"99","author":"K Hiraoka","year":"2008","unstructured":"Hiraoka, K., Zenmyo, M., Watari, K., Iguchi, H., Fotovati, A., Kimura, Y. N., Hosoi, F., Shoda, T., Nagata, K., Osada, H., Ono, M., & Kuwano, M. (2008). Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes\/macrophages. Cancer Science, 99, 1595\u20131602.","journal-title":"Cancer Science"},{"key":"9965_CR43","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.2174\/138161210793563635","volume":"16","author":"AJ Roelofs","year":"2010","unstructured":"Roelofs, A. J., Thompson, K., Ebetino, F. H., Rogers, M. J., & Coxon, F. P. (2010). Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Current Pharmaceutical Design, 16, 2950\u20132960.","journal-title":"Current Pharmaceutical Design"},{"key":"9965_CR44","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2217\/imt.13.102","volume":"5","author":"RZ Panni","year":"2013","unstructured":"Panni, R. Z., Linehan, D. C., & DeNardo, D. G. (2013). Targeting tumor-infiltrating macrophages to combat cancer. Immunotherapy, 5, 1075\u20131087.","journal-title":"Immunotherapy"},{"key":"9965_CR45","doi-asserted-by":"crossref","unstructured":"Kaur, S., et al. (2017). Role of bone marrow macrophages in controlling homeostasis and repair in bone and bone marrow niches. In Seminars in cell & developmental biology (Vol. 61, pp. 12\u201321). Elsevier.","DOI":"10.1016\/j.semcdb.2016.08.009"},{"key":"9965_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neo.2018.11.003","volume":"21","author":"JD Jones","year":"2019","unstructured":"Jones, J. D., Sinder, B. P., Paige, D., Soki, F. N., Koh, A. J., Thiele, S., Shiozawa, Y., Hofbauer, L. C., Daignault, S., Roca, H., & McCauley, L. K. (2019). Trabectedin reduces skeletal prostate cancer tumor size in association with effects on M2 macrophages and efferocytosis. Neoplasia, 21, 172\u2013184.","journal-title":"Neoplasia"},{"key":"9965_CR47","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.7150\/thno.29617","volume":"9","author":"P Jiang","year":"2019","unstructured":"Jiang, P., Gao, W., Ma, T., Wang, R., Piao, Y., Dong, X., Wang, P., Zhang, X., Liu, Y., Su, W., Xiang, R., Zhang, J., & Li, N. (2019). CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes\/macrophages. Theranostics, 9, 2950\u20132966.","journal-title":"Theranostics"},{"key":"9965_CR48","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1073\/pnas.0702095104","volume":"104","author":"AL Welm","year":"2007","unstructured":"Welm, A. L., Sneddon, J. B., Taylor, C., Nuyten, D. S. A., van de Vijver, M. J., Hasegawa, B. H., & Bishop, J. M. (2007). The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proceedings of the National Academy of Sciences, 104, 7570\u20137575.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9965_CR49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/srep00906","volume":"2","author":"SA Patel","year":"2012","unstructured":"Patel, S. A., Ramkissoon, S. H., Bryan, M., Pliner, L. F., Dontu, G., Patel, P. S., Amiri, S., Pine, S. R., & Rameshwar, P. (2012). Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Scientific Reports, 2, 906.","journal-title":"Scientific Reports"},{"key":"9965_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41419-019-1304-z","volume":"10","author":"ND Walker","year":"2019","unstructured":"Walker, N. D., Elias, M., Guiro, K., Bhatia, R., Greco, S. J., Bryan, M., Gergues, M., Sandiford, O. A., Ponzio, N. M., Leibovich, S. J., & Rameshwar, P. (2019). Exosomes from differentially activated macrophages influence dormancy or resurgence of breast cancer cells within bone marrow stroma. Cell Death & Disease, 10, 59.","journal-title":"Cell Death & Disease"},{"key":"9965_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1304-z","volume":"10","author":"ND Walker","year":"2019","unstructured":"Walker, N. D., et al. (2019). Exosomes from differentially activated macrophages influence dormancy or resurgence of breast cancer cells within bone marrow stroma. Cell Death & Disease, 10, 1\u201316.","journal-title":"Cell Death & Disease"},{"key":"9965_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/onc.2015.132","volume":"35","author":"C Raggi","year":"2016","unstructured":"Raggi, C., Mousa, H. S., Correnti, M., Sica, A., & Invernizzi, P. (2016). Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies. Oncogene, 35, 671\u2013682.","journal-title":"Oncogene"},{"key":"9965_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R., & Pollard, J. W. (2014). Tumor-associated macrophages: from mechanisms to therapy. Immunity, 41, 49\u201361.","journal-title":"Immunity"},{"key":"9965_CR54","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/s41401-019-0262-4","volume":"40","author":"X-J Shao","year":"2019","unstructured":"Shao, X.-J., et al. (2019). Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells. Acta Pharmacologica Sinica, 40, 1343\u20131350.","journal-title":"Acta Pharmacologica Sinica"},{"key":"9965_CR55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/9780470035399.ch9","volume":"279","author":"RM Steinman","year":"2006","unstructured":"Steinman, R. M. (2006). Linking innate to adaptive immunity through dendritic cells. Novartis Foundation Symposium, 279, 101\u2013109; discussion 109-113, 216-109.","journal-title":"Novartis Foundation Symposium"},{"key":"9965_CR56","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1084\/jem.20071995","volume":"204","author":"H Bashyam","year":"2007","unstructured":"Bashyam, H. (2007). Ralph Steinman: dendritic cells bring home the Lasker. The Journal of Experimental Medicine, 204, 2245\u20132248.","journal-title":"The Journal of Experimental Medicine"},{"key":"9965_CR57","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nri3712","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, E., Tussiwand, R., & Yona, S. (2014). Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nature Reviews. Immunology, 14, 571\u2013578.","journal-title":"Nature Reviews. Immunology"},{"key":"9965_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ki.2008.99","volume":"74","author":"S Segerer","year":"2008","unstructured":"Segerer, S., Heller, F., Lindenmeyer, M. T., Schmid, H., Cohen, C. D., Draganovici, D., Mandelbaum, J., Nelson, P. J., Gr\u00f6ne, H. J., Gr\u00f6ne, E. F., Figel, A. M., N\u00f6ssner, E., & Schl\u00f6ndorff, D. (2008). Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney International, 74, 37\u201346.","journal-title":"Kidney International"},{"key":"9965_CR59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1074-7613(03)00352-2","volume":"20","author":"C Ardavin","year":"2004","unstructured":"Ardavin, C. (2004). Amigorena, S. & Reis e Sousa, C. Dendritic cells: immunobiology and cancer immunotherapy. Immunity, 20, 17\u201323.","journal-title":"Immunity"},{"key":"9965_CR60","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.4049\/jimmunol.160.8.4090","volume":"160","author":"BN Lambrecht","year":"1998","unstructured":"Lambrecht, B. N., Salomon, B., Klatzmann, D., & Pauwels, R. A. (1998). Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. Journal of Immunology, 160, 4090\u20134097.","journal-title":"Journal of Immunology"},{"key":"9965_CR61","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1634\/theoncologist.2010-0327","volume":"16","author":"M Tucci","year":"2011","unstructured":"Tucci, M., Stucci, S., Strippoli, S., Dammacco, F., & Silvestris, F. (2011). Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? Oncologist, 16, 1040\u20131048.","journal-title":"Oncologist"},{"key":"9965_CR62","doi-asserted-by":"crossref","unstructured":"Wang, B., Dong, Y., Tian, Z., Chen, Y., & Dong, S. (2020). The role of dendritic cells derived osteoclasts in bone destruction diseases. Genes & Diseases.","DOI":"10.1016\/j.gendis.2020.03.009"},{"key":"9965_CR63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","volume":"45","author":"F Veglia","year":"2017","unstructured":"Veglia, F., & Gabrilovich, D. I. (2017). Dendritic cells in cancer: the role revisited. Current Opinion in Immunology, 45, 43\u201351.","journal-title":"Current Opinion in Immunology"},{"key":"9965_CR64","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.4049\/jimmunol.1101855","volume":"189","author":"A Sawant","year":"2012","unstructured":"Sawant, A., Hensel, J. A., Chanda, D., Harris, B. A., Siegal, G. P., Maheshwari, A., & Ponnazhagan, S. (2012). Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. Journal of Immunology, 189, 4258\u20134265.","journal-title":"Journal of Immunology"},{"key":"9965_CR65","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3389\/fimmu.2017.01781","volume":"8","author":"A Lin","year":"2017","unstructured":"Lin, A., & Lore, K. (2017). Granulocytes: new members of the antigen-presenting cell family. Frontiers in Immunology, 8, 1781.","journal-title":"Frontiers in Immunology"},{"key":"9965_CR66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.it.2013.04.002","volume":"34","author":"B Geering","year":"2013","unstructured":"Geering, B., Stoeckle, C., Conus, S., & Simon, H. U. (2013). Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends in Immunology, 34, 398\u2013409.","journal-title":"Trends in Immunology"},{"key":"9965_CR67","doi-asserted-by":"publisher","first-page":"9748345","DOI":"10.1155\/2017\/9748345","volume":"2017","author":"C Rosales","year":"2017","unstructured":"Rosales, C., Lowell, C. A., Schnoor, M., & Uribe-Querol, E. (2017). Neutrophils: their role in innate and adaptive immunity 2017. Journal of Immunology Research, 2017, 9748345.","journal-title":"Journal of Immunology Research"},{"key":"9965_CR68","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","volume":"30","author":"B Amulic","year":"2012","unstructured":"Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012). Neutrophil function: from mechanisms to disease. Annual Review of Immunology, 30, 459\u2013489.","journal-title":"Annual Review of Immunology"},{"key":"9965_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/2326-6066.CIR-15-0313","volume":"4","author":"W Liang","year":"2016","unstructured":"Liang, W., & Ferrara, N. (2016). The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunology Research, 4, 83\u201391.","journal-title":"Cancer Immunology Research"},{"key":"9965_CR70","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI37223","volume":"120","author":"J Jablonska","year":"2010","unstructured":"Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010). Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. The Journal of Clinical Investigation, 120, 1151\u20131164.","journal-title":"The Journal of Clinical Investigation"},{"key":"9965_CR71","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1061175","volume":"5","author":"Y Liu","year":"2016","unstructured":"Liu, Y., O'Leary, C. E., Wang, L. C. S., Bhatti, T. R., Dai, N., Kapoor, V., Liu, P., Mei, J., Guo, L., Oliver, P. M., Albelda, S. M., & Worthen, G. S. (2016). CD11b+ Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis. Oncoimmunology, 5, e1061175.","journal-title":"Oncoimmunology"},{"key":"9965_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009). Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2:\u201cN1\u201d versus \u201cN2\u201d TAN. Cancer cell, 16, 183\u2013194.","journal-title":"Cancer cell"},{"key":"9965_CR73","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/ijc.29945","volume":"138","author":"L Andzinski","year":"2016","unstructured":"Andzinski, L., Kasnitz, N., Stahnke, S., Wu, C. F., Gereke, M., von K\u00f6ckritz-Blickwede, M., Schilling, B., Brandau, S., Weiss, S., & Jablonska, J. (2016). Type I IFN s induce anti-tumor polarization of tumor associated neutrophils in mice and human. International Journal of Cancer, 138, 1982\u20131993.","journal-title":"International Journal of Cancer"},{"key":"9965_CR74","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.4049\/jimmunol.1201881","volume":"190","author":"B Yan","year":"2013","unstructured":"Yan, B., Wei, J. J., Yuan, Y., Sun, R., Li, D., Luo, J., Liao, S. J., Zhou, Y. H., Shu, Y., Wang, Q., Zhang, G. M., & Feng, Z. H. (2013). IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation. Journal of Immunology, 190, 5882\u20135893.","journal-title":"Journal of Immunology"},{"key":"9965_CR75","doi-asserted-by":"publisher","first-page":"E566","DOI":"10.1073\/pnas.1424927112","volume":"112","author":"A-J Casbon","year":"2015","unstructured":"Casbon, A.-J., Reynaud, D., Park, C., Khuc, E., Gan, D. D., Schepers, K., Passegu\u00e9, E., & Werb, Z. (2015). Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proceedings of the National Academy of Sciences, 112, E566\u2013E575.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9965_CR76","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12885-018-4189-9","volume":"18","author":"M Kim","year":"2018","unstructured":"Kim, M., Song, C., Jeong, I. G., Choi, S. K., Park, M., Shim, M., Kim, Y. S., You, D., Hong, J. H., Kim, C. S., & Ahn, H. (2018). Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study. BMC Cancer, 18, 271.","journal-title":"BMC Cancer"},{"key":"9965_CR77","doi-asserted-by":"crossref","unstructured":"Costanzo-Garvey, D. L., Keeley, T., Case, A. J., Watson, G. F., Alsamraae M., Yu Y., Su, K., Heim, C. E., Kielian T., Morrissey, C., Frieling, J. S., & Cook, L. M. (2020). Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunology, Immunotherapy, 1\u201318.","DOI":"10.1007\/s00262-020-02527-6"},{"key":"9965_CR78","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/sj.bjc.6600864","volume":"88","author":"SO Gollnick","year":"2003","unstructured":"Gollnick, S. O., Evans, S. S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang, W. C., Unger, E., & Henderson, B. W. (2003). Role of cytokines in photodynamic therapy-induced local and systemic inflammation. British Journal of Cancer, 88, 1772\u20131779.","journal-title":"British Journal of Cancer"},{"key":"9965_CR79","doi-asserted-by":"crossref","unstructured":"Chu, D., Dong, X., Zhao, Q., Gu, J., & Wang, Z. (2017). Photosensitization priming of tumor microenvironments improves delivery of nanotherapeutics via neutrophil infiltration. Advanced Materials, 29.","DOI":"10.1002\/adma.201701021"},{"key":"9965_CR80","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","volume":"11","author":"T Kang","year":"2017","unstructured":"Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., & Chen, J. (2017). Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano, 11, 1397\u20131411.","journal-title":"ACS Nano"},{"key":"9965_CR81","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.trecan.2019.10.013","volume":"5","author":"T Keeley","year":"2019","unstructured":"Keeley, T., Costanzo-Garvey, D. L., & Cook, L. M. (2019). Unmasking the many faces of tumor-associated neutrophils and macrophages: considerations for targeting innate immune cells in cancer. Trends Cancer, 5, 789\u2013798.","journal-title":"Trends Cancer"},{"key":"9965_CR82","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3389\/fimmu.2018.02776","volume":"9","author":"S Budhwar","year":"2018","unstructured":"Budhwar, S., Verma, P., Verma, R., Rai, S., & Singh, K. (2018). The yin and yang of myeloid derived suppressor cells. Frontiers in Immunology, 9, 2776.","journal-title":"Frontiers in Immunology"},{"key":"9965_CR83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fimmu.2015.00523","volume":"6","author":"Y Meirow","year":"2015","unstructured":"Meirow, Y., Kanterman, J., & Baniyash, M. (2015). Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate. Frontiers in Immunology, 6, 523.","journal-title":"Frontiers in Immunology"},{"key":"9965_CR84","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3109\/08820139.2012.680634","volume":"41","author":"P Raber","year":"2012","unstructured":"Raber, P., Ochoa, A. C., & Rodr\u00edguez, P. C. (2012). Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunological Investigations, 41, 614\u2013634.","journal-title":"Immunological Investigations"},{"key":"9965_CR85","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan, C. (2001). Nitric oxide and the immune response. Nature Immunology, 2, 907\u2013916.","journal-title":"Nature Immunology"},{"key":"9965_CR86","doi-asserted-by":"crossref","unstructured":"Parker, K. H., Beury, D. W., & Ostrand-Rosenberg, S. (2015). Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment. In Advances in cancer research (Vol. 128, pp. 95\u2013139). Elsevier.","DOI":"10.1016\/bs.acr.2015.04.002"},{"key":"9965_CR87","doi-asserted-by":"crossref","unstructured":"Umansky, V., Blattner, C., Gebhardt, C., & Utikal, J. (2016). The role of myeloid-derived suppressor cells (MDSC) in cancer progression. Vaccines (Basel), 4.","DOI":"10.3390\/vaccines4040036"},{"key":"9965_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41392-020-00377-3","volume":"6","author":"J Chen","year":"2021","unstructured":"Chen, J., Sun, H. W., Yang, Y. Y., Chen, H. T., Yu, X. J., Wu, W. C., Xu, Y. T., Jin, L. L., Wu, X. J., Xu, J., & Zheng, L. (2021). Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduction and Targeted Therapy, 6, 4.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"9965_CR89","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00262-008-0609-z","volume":"58","author":"JK Morales","year":"2009","unstructured":"Morales, J. K., Kmieciak, M., Graham, L., Feldmesser, M., Bear, H. D., & Manjili, M. H. (2009). Adoptive transfer of HER2\/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunology, Immunotherapy, 58, 941\u2013953.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"9965_CR90","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","volume":"73","author":"A Sawant","year":"2013","unstructured":"Sawant, A., Deshane, J., Jules, J., Lee, C. M., Harris, B. A., Feng, X., & Ponnazhagan, S. (2013). Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Research, 73, 672\u2013682.","journal-title":"Cancer Research"},{"key":"9965_CR91","doi-asserted-by":"publisher","first-page":"172773","DOI":"10.1016\/j.ejphar.2019.172773","volume":"866","author":"A Kuznik","year":"2020","unstructured":"Kuznik, A., Pazdzierniok-Holewa, A., Jewula, P., & Kuznik, N. (2020). Bisphosphonates-much more than only drugs for bone diseases. European Journal of Pharmacology, 866, 172773.","journal-title":"European Journal of Pharmacology"},{"key":"9965_CR92","doi-asserted-by":"publisher","first-page":"11438","DOI":"10.1158\/0008-5472.CAN-07-1882","volume":"67","author":"C Melani","year":"2007","unstructured":"Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., & Colombo, M. P. (2007). Amino-biphosphonate\u2013mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Research, 67, 11438\u201311446.","journal-title":"Cancer Research"},{"key":"9965_CR93","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4049\/jimmunol.1701019","volume":"200","author":"S Ostrand-Rosenberg","year":"2018","unstructured":"Ostrand-Rosenberg, S., & Fenselau, C. (2018). Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. Journal of Immunology, 200, 422\u2013431.","journal-title":"Journal of Immunology"},{"key":"9965_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","volume":"66","author":"T Condamine","year":"2015","unstructured":"Condamine, T., Ramachandran, I., Youn, J. I., & Gabrilovich, D. I. (2015). Regulation of tumor metastasis by myeloid-derived suppressor cells. Annual Review of Medicine, 66, 97\u2013110.","journal-title":"Annual Review of Medicine"},{"key":"9965_CR95","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1084\/jem.20181952","volume":"216","author":"J Mastio","year":"2019","unstructured":"Mastio, J., Condamine, T., Dominguez, G., Kossenkov, A. V., Donthireddy, L., Veglia, F., Lin, C., Wang, F., Fu, S., Zhou, J., Viatour, P., Lavilla-Alonso, S., Polo, A. T., Tcyganov, E. N., Mulligan Jr., C., Nam, B., Bennett, J., Masters, G., Guarino, M., Kumar, A., Nefedova, Y., Vonderheide, R. H., Languino, L. R., Abrams, S. I., & Gabrilovich, D. I. (2019). Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs. Journal of Experimental Medicine, 216, 2150\u20132169.","journal-title":"Journal of Experimental Medicine"},{"key":"9965_CR96","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","volume":"179","author":"P Sinha","year":"2007","unstructured":"Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007). Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. Journal of Immunology, 179, 977\u2013983.","journal-title":"Journal of Immunology"},{"key":"9965_CR97","doi-asserted-by":"publisher","first-page":"19434","DOI":"10.1073\/pnas.0704535104","volume":"104","author":"I Mulero","year":"2007","unstructured":"Mulero, I., Sepulcre, M. P., Meseguer, J., Garc\u00eda-Ayala, A., & Mulero, V. (2007). Histamine is stored in mast cells of most evolutionarily advanced fish and regulates the fish inflammatory response. Proceedings of the National Academy of Sciences, 104, 19434\u201319439.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9965_CR98","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1471-4906(02)02274-3","volume":"23","author":"G Marone","year":"2002","unstructured":"Marone, G., Galli, S. J., & Kitamura, Y. (2002). Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. Trends in Immunology, 23, 425\u2013427.","journal-title":"Trends in Immunology"},{"key":"9965_CR99","first-page":"2333","volume":"94","author":"AS Kirshenbaum","year":"1999","unstructured":"Kirshenbaum, A. S., et al. (1999). Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13). Blood, The Journal of the American Society of Hematology, 94, 2333\u20132342.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"9965_CR100","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3390\/ijms20092106","volume":"20","author":"G Sammarco","year":"2019","unstructured":"Sammarco, G., Varricchi, G., Ferraro, V., Ammendola, M., de Fazio, M., Altomare, D. F., Luposella, M., Maltese, L., Curr\u00f2, G., Marone, G., Ranieri, G., & Memeo, R. (2019). Mast cells, angiogenesis and lymphangiogenesis in human gastric cancer. International Journal of Molecular Sciences, 20, 2106.","journal-title":"International Journal of Molecular Sciences"},{"key":"9965_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-6-56","volume":"6","author":"GY Jim\u00e9nez-Andrade","year":"2013","unstructured":"Jim\u00e9nez-Andrade, G. Y., Ibarra-S\u00e1nchez, A., Gonz\u00e1lez, D., Lamas, M., & Gonz\u00e1lez-Espinosa, C. (2013). Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism. Journal of Hematology & Oncology, 6, 1\u201314.","journal-title":"Journal of Hematology & Oncology"},{"key":"9965_CR102","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/CMR.0000000000000192","volume":"25","author":"H Siiskonen","year":"2015","unstructured":"Siiskonen, H., Poukka, M., Bykachev, A., Tyynel\u00e4-Korhonen, K., Sironen, R., Pasonen-Sepp\u00e4nen, S., & Harvima, I. T. (2015). Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma. Melanoma Research, 25, 479\u2013485.","journal-title":"Melanoma Research"},{"key":"9965_CR103","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bjc.6690070","volume":"79","author":"D Ribatti","year":"1999","unstructured":"Ribatti, D., Vacca, A., Nico, B., Quondamatteo, F., Ria, R., Minischetti, M., Marzullo, A., Herken, R., Roncali, L., & Dammacco, F. (1999). Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. British Journal of Cancer, 79, 451\u2013455.","journal-title":"British Journal of Cancer"},{"key":"9965_CR104","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000443275","volume":"168","author":"R Vyzoukaki","year":"2015","unstructured":"Vyzoukaki, R., Tsirakis, G., Pappa, C. A., Devetzoglou, M., Tzardi, M., & Alexandrakis, M. G. (2015). The impact of mast cell density on the progression of bone disease in multiple myeloma patients. International Archives of Allergy and Immunology, 168, 263\u2013268.","journal-title":"International Archives of Allergy and Immunology"},{"key":"9965_CR105","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.3748\/wjg.v21.i37.10493","volume":"21","author":"C Leporini","year":"2015","unstructured":"Leporini, C., Ammendola, M., Marech, I., Sammarco, G., Sacco, R., Gadaleta, C. D., Oakley, C., Russo, E., de Sarro, G., & Ranieri, G. (2015). Targeting mast cells in gastric cancer with special reference to bone metastases. World journal of gastroenterology: WJG, 21, 10493\u201310501.","journal-title":"World journal of gastroenterology: WJG"},{"key":"9965_CR106","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3390\/ijms16023237","volume":"16","author":"M Ammendola","year":"2015","unstructured":"Ammendola, M., Marech, I., Sammarco, G., Zuccal\u00e0, V., Luposella, M., Zizzo, N., Patruno, R., Crovace, A., Ruggieri, E., Zito, A., Gadaleta, C., Sacco, R., & Ranieri, G. (2015). Infiltrating mast cells correlate with angiogenesis in bone metastases from gastric cancer patients. International Journal of Molecular Sciences, 16, 3237\u20133250.","journal-title":"International Journal of Molecular Sciences"},{"key":"9965_CR107","volume-title":"Thrombopoietin: the primary regulator of platelet production [see comments]","author":"K Kaushansky","year":"1995","unstructured":"Kaushansky, K. Thrombopoietin: the primary regulator of platelet production [see comments]. (1995)."},{"key":"9965_CR108","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2014-01-547638","volume":"124","author":"LM Niswander","year":"2014","unstructured":"Niswander, L. M., Fegan, K. H., Kingsley, P. D., McGrath, K. E., & Palis, J. (2014). SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury. Blood, 124, 277\u2013286.","journal-title":"Blood"},{"key":"9965_CR109","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bone.2006.05.004","volume":"39","author":"MA Kacena","year":"2006","unstructured":"Kacena, M. A., Nelson, T., Clough, M. E., Lee, S. K., Lorenzo, J. A., Gundberg, C. M., & Horowitz, M. C. (2006). Megakaryocyte-mediated inhibition of osteoclast development. Bone, 39, 991\u2013999.","journal-title":"Bone"},{"key":"9965_CR110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jbmr.204","volume":"26","author":"X Li","year":"2011","unstructured":"Li, X., Koh, A. J., Wang, Z., Soki, F. N., Park, S. I., Pienta, K. J., & McCauley, L. K. (2011). Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis. Journal of Bone and Mineral Research, 26, 125\u2013134.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9965_CR111","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-16-1084","volume":"77","author":"W Jackson","year":"2017","unstructured":"Jackson, W., et al. (2017). Role of megakaryocytes in breast cancer metastasis to bone. Cancer Research, 77, 1942\u20131954.","journal-title":"Cancer Research"},{"key":"9965_CR112","first-page":"24","volume":"128","author":"R Leblanc","year":"2016","unstructured":"Leblanc, R., & Peyruchaud, O. (2016). Metastasis: new functional implications of platelets and megakaryocytes. Blood, The Journal of the American Society of Hematology, 128, 24\u201331.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"9965_CR113","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0008-6363(00)00230-3","volume":"49","author":"D English","year":"2001","unstructured":"English, D., Garcia, J. G., & Brindley, D. (2001). Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovascular Research, 49, 588\u2013599.","journal-title":"Cardiovascular Research"},{"key":"9965_CR114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S., & Cheresh, D. A. (2010). Integrins in cancer: biological implications and therapeutic opportunities. Nature Reviews. Cancer, 10, 9\u201322.","journal-title":"Nature Reviews. Cancer"},{"key":"9965_CR115","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi, H., & Ivaska, J. (2018). Every step of the way: integrins in cancer progression and metastasis. Nature Reviews. Cancer, 18, 533\u2013548.","journal-title":"Nature Reviews. Cancer"},{"key":"9965_CR116","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1073\/pnas.2234372100","volume":"100","author":"SJ Bakewell","year":"2003","unstructured":"Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., & Weilbaecher, K. N. (2003). Platelet and osteoclast \u03b23 integrins are critical for bone metastasis. Proceedings of the National Academy of Sciences, 100, 14205\u201314210.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9965_CR117","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jcb.21709","volume":"104","author":"\u00d6 Ulu\u00e7kan","year":"2008","unstructured":"Ulu\u00e7kan, \u00d6., Eagleton, M. C., Floyd, D. H., Morgan, E. A., Hirbe, A. C., Kramer, M., Dowland, N., Prior, J. L., Piwnica-Worms, D., Jeong, S. S., Chen, R., & Weilbaecher, K. (2008). APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. Journal of Cellular Biochemistry, 104, 1311\u20131323.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9965_CR118","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1172\/JCI200422123","volume":"114","author":"A Boucharaba","year":"2004","unstructured":"Boucharaba, A., Serre, C. M., Gr\u00e8s, S., Saulnier-Blache, J. S., Bordet, J. C., Guglielmi, J., Cl\u00e9zardin, P., & Peyruchaud, O. (2004). Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. The Journal of Clinical Investigation, 114, 1714\u20131725.","journal-title":"The Journal of Clinical Investigation"},{"key":"9965_CR119","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.yexcr.2014.11.010","volume":"333","author":"R Leblanc","year":"2015","unstructured":"Leblanc, R., & Peyruchaud, O. (2015). New insights into the autotaxin\/LPA axis in cancer development and metastasis. Experimental Cell Research, 333, 183\u2013189.","journal-title":"Experimental Cell Research"},{"key":"9965_CR120","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1111\/bph.14362","volume":"175","author":"R Leblanc","year":"2018","unstructured":"Leblanc, R., Houssin, A., & Peyruchaud, O. (2018). Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis. British Journal of Pharmacology, 175, 3100\u20133110.","journal-title":"British Journal of Pharmacology"},{"key":"9965_CR121","volume-title":"Interaction of platelet-derived autotaxin with tumor integrin aVb3 controls metastasis of breast cancer cells to bone","author":"A Nontumoral","year":"2014","unstructured":"Nontumoral, A. Interaction of platelet-derived autotaxin with tumor integrin aVb3 controls metastasis of breast cancer cells to bone. (2014)."},{"key":"9965_CR122","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1096\/fj.13-248641","volume":"28","author":"MG Benesch","year":"2014","unstructured":"Benesch, M. G., et al. (2014). Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice. The FASEB Journal, 28, 2655\u20132666.","journal-title":"The FASEB Journal"},{"key":"9965_CR123","first-page":"321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo, F., et al. (2017). Bone Metastases: An Overview. Oncol Rev, 11, 321.","journal-title":"Bone Metastases: An Overview. Oncol Rev"},{"key":"9965_CR124","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00109-015-1329-4","volume":"93","author":"G Ren","year":"2015","unstructured":"Ren, G., Esposito, M., & Kang, Y. (2015). Bone metastasis and the metastatic niche. Journal of Molecular Medicine (Berlin, Germany), 93, 1203\u20131212.","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"9965_CR125","doi-asserted-by":"publisher","first-page":"421746","DOI":"10.1155\/2015\/421746","volume":"2015","author":"R Florencio-Silva","year":"2015","unstructured":"Florencio-Silva, R., Sasso, G. R., Sasso-Cerri, E., Simoes, M. J., & Cerri, P. S. (2015). Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. BioMed Research International, 2015, 421746.","journal-title":"BioMed Research International"},{"key":"9965_CR126","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12967-019-1866-7","volume":"17","author":"R Schafer","year":"2019","unstructured":"Schafer, R., et al. (2019). Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentration. Journal of Translational Medicine, 17, 115.","journal-title":"Journal of Translational Medicine"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-09965-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-021-09965-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-09965-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T23:57:31Z","timestamp":1698883051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-021-09965-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9965"],"URL":"https:\/\/doi.org\/10.1007\/s10555-021-09965-3","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}